Skip to main content
Premium Trial:

Request an Annual Quote

PerkinElmer and BioImage to Co-Develop Cell-Based Screening Offering

NEW YORK, Aug. 25 (GenomeWeb News) - PerkinElmer will collaborate with Danish drug discovery firm BioImage to develop cell-based assays for drug screening, PerkinElmer said today.

 

Under the terms of the agreement, the companies will combine BioImage's assay methods and reagents for measuring protein-protein interactions with PerkinElmer's Envision fluorometric detection instrument. PerkinElmer said that BioImage, based in Copenhagen, has already developed a suite of assays to be used on the Envision platform.

 

Financial terms of the deal were not disclosed.

The Scan

Genetic Tests Lead to Potential Prognostic Variants in Dutch Children With Dilated Cardiomyopathy

Researchers in Circulation: Genomic and Precision Medicine found that the presence of pathogenic or likely pathogenic variants was linked to increased risk of death and poorer outcomes in children with pediatric dilated cardiomyopathy.

Fragile X Syndrome Mutations Found With Comprehensive Testing Method

Researchers in Clinical Chemistry found fragile X syndrome expansions and other FMR1 mutations with ties to the intellectual disability condition using a long-range PCR and long-read sequencing approach.

Team Presents Strategy for Speedy Species Detection in Metagenomic Sequence Data

A computational approach presented in PLOS Computational Biology produced fewer false-positive species identifications in simulated and authentic metagenomic sequences.

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.